ArticleScientific reports2026
Risk of bleeding in transbronchial biopsies in patients with pulmonary hypertension.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to identify key risk factors associated with bleeding after transbronchial biopsies in patients living in Bogotá, Colombia (2,640 m above sea level). A retrospective cohort study was conducted in adult patients who underwent bronchoscopy with transbronchial biopsies. Postbronchoscopy bleeding was classified according to the British Thoracic Society criteria. Logistic regression analyses were performed to investigate the relationships between the variables and postbronchoscopy bleeding. Among 208 participants (54.3% male, median age 69 years, IQR 56–77), bleeding occurred in 78 procedures (37.5%), most of which were mild (76.9%). A moderate to high probability of pulmonary hypertension on echocardiography was found in 31.2% of patients; a high probability of pulmonary hypertension on computed tomography scan was found in 66.8% of patients. No significant associations were found between bleeding risk and a moderate to high probability of pulmonary hypertension on echocardiography (OR 0.79, 95% CI 0.28–2.15; p = 0.896) or a high probability on computed tomography (OR 0.66; 95% CI 0.29–1.49; p = 0.848). Chronic obstructive pulmonary disease was associated with postbronchoscopy bleeding (OR 2.79, 95% CI 1.26–6.19; p = 0.012). The results support that the probability of pulmonary hypertension on echocardiography or computed tomography is not associated with postbronchoscopy bleeding but suggest that chronic obstructive pulmonary disease is a relevant factor to consider.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.